Ainos Inc. stock surges amid market gains
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 28 Jan 26
Source: Benzinga
Ainos Inc. shares rose by 50.00% in pre-market trading, crossing above the 5-day SMA, reflecting strong investor interest.
The significant price increase is attributed to broad market strength, as both the Nasdaq-100 and S&P 500 indices posted gains of 0.77% and 0.28%, respectively. This positive market environment has likely contributed to the heightened demand for Ainos Inc. shares.
The implications of this surge suggest a growing confidence among investors in Ainos Inc.'s potential, possibly leading to increased trading volume and interest in the company's future developments.
Analyst Views on AIMD
About AIMD
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





